Liraglutide Injection 3 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 3 mg/mL
Reference Brands: Saxenda(US & EU), Victoza (India/USA)
Category: Weight Loss drugs
Saxenda (liraglutide 3 mg) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and increases satiety. It supports weight loss, improves metabolic health, and helps manage obesity. Benefits include appetite suppression, significant weight reduction, improved blood sugar control, and enhanced overall wellness.
Product Description:
Saxenda (liraglutide 3 mg) is approved in the US by the FDA and in the EU via EMA for chronic weight management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews trial and quality data promptly, while EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, helping patients worldwide achieve significant weight loss and metabolic health improvements through high-quality Saxenda therapy supported by regional regulations.
Liraglutide Injection — third party manufacturing & bulk supply
Liraglutide Injection 3 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Liraglutide Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Liraglutide Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Liraglutide is used to manage Type 2 diabetes mellitus and obesity. It helps control blood sugar levels, improves glycemic parameters, and supports weight reduction in patients with excess body weight. It is also prescribed to reduce cardiovascular risk factors in patients with diabetes.
Liraglutide is a synthetic analogue of human glucagon-like peptide-1 (GLP-1), produced using recombinant DNA technology. It acts as a GLP-1 receptor agonist to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite.
The main trade names are Victoza (for Type 2 diabetes) and Saxenda (for obesity/weight management).
Liraglutide is manufactured by Novo Nordisk, a global leader in diabetes and obesity therapeutics.
The generic name is Liraglutide.
Brand names include Victoza and Saxenda.
Liraglutide is manufactured in Denmark by Novo Nordisk and distributed globally, including the USA, EU, Japan, India, and other regions.
Related Products
Phendimetrazine Tartrate
Strength:
35 mg, 105 mg
Form: Capsules
Reference Brands: Bontril (USA), Plegine (USA)
View Details
Phentermine Hydrochloride
Strength:
8 mg, 15 mg, 30 mg, 37.5 mg
Form: Tablets, Capsules
Reference Brands: Adipex-P (USA), Ionamin (USA)
View Details
Diethylpropion Hydrochloride
Strength:
25mg, 75mg
Form: Tablets
Reference Brands: Tenuate (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
